2095 POSTER A randomized, open-label CECOG phase II study of dose-dense FEC 75 vs FEC 90 as adjuvant therapy in early breast cancer patients

2007 ◽  
Vol 5 (4) ◽  
pp. 211-212 ◽  
Author(s):  
S. Kahan ◽  
S. Spanik ◽  
M. Wagnerova ◽  
T. Skacel ◽  
B. Planko ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Therapy ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Breast Cancer Patients ◽  
Open Label ◽  
Dose Dense

scholarly journals P231 Phase II study on radiofrequency ablation for early breast cancer patients

The Breast ◽  
2011 ◽  
Vol 20 ◽  
pp. S54-S55
Author(s):  
S. Moto ◽  
H. Osaka ◽  
N. Sakemura ◽  
H. Ito ◽  
K. Imi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiofrequency Ablation ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Breast Cancer Patients

Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study

2009 ◽  
Vol 49 (1) ◽  
pp. 35-41 ◽  
Author(s):  
Annika Malmström ◽  
Jörgen Hansen ◽  
Lena Malmberg ◽  
Lena Carlsson ◽  
Jan-Henry Svensson ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Breast Cancer Patients ◽  
Treated Breast ◽  
Treated Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document